Table 2 Imaging characteristics
From: 5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
5ARI users | Non-5ARI users | |
|---|---|---|
Prostate volume | 64.9 | 48.1 |
Index PIRADS lesion | ||
1–2 | 3 (5.56%) | 27 (9.09%) |
3 | 23 (42.6%) | 88 (29.6%) |
4 | 21 (38.9%) | 145 (48.8%) |
5 | 7 (13.0%) | 37 (12.5%) |
Number of lesions | ||
0 | 3 (5.55%) | 18 (6.06%) |
1 | 34 (63.0%) | 186 (62.6%) |
2 | 12 (22.2%) | 69 (23.2%) |
3 | 3 (5.55%) | 19 (6.39%) |
4 | 1 (1.85%) | 5 (1.68%) |
5 | 1 (1.85%) | 0 |
Location of index lesion | ||
Peripheral zone | 35 (68.6%) | 192 (69.3%) |
Transitional zone | 16 (31.4%) | 84 (30.3%) |
Anterior | 0 (0%) | 1 (0.4%) |